Mary F. Brunette, MD
- 6Articles
- 25.7KReads
- 2004–2020Active
- 32Collaborators
- 209Citations
About
Mary F. Brunette, MD, has authored multiple articles on schizophrenia, schizoaffective disorders, and addiction, focusing on clinical trials and treatment approaches for patients with co-occurring mental illness and substance use disorders. Her work includes studies on pharmacological interventions such as olanzapine with samidorphan and risperidone formulations, as well as psychosocial management strategies for severe mental illness with substance abuse. Brunette's research spans early treatment programs for first-episode psychosis and prescription practices involving benzodiazepines in this population.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
